University Clinic of Regensburg, Department of Psychosomatics, Germany.
J Psychosom Res. 2013 Sep;75(3):255-61. doi: 10.1016/j.jpsychores.2013.07.003. Epub 2013 Aug 2.
Although psychosomatic in-patient treatment is effective, 5-10% of the patients deteriorate. Providing patient progress feedback and clinical support tools to therapists improves the outcome for patients at risk of deterioration in counseling, outpatient psychotherapy, and substance abuse treatment. This study investigated the effects of feedback on psychosomatically treated in-patients at risk of treatment failure.
At intake, all patients of two psychosomatic clinics were randomized either into the experimental group or the treatment-as-usual control group. Both groups were tracked weekly with the "Outcome Questionnaire" (OQ-45) measuring patient progress and with the clinical support tool "Assessment of Signal Cases" (ASC). Therapists received feedback from both instruments for all their experimental group patients. "Patients at risk" were defined as patients who deviated from expected recovery curves by at least one standard deviation. Of 252 patients, 43 patients were at risk: 23 belonged to the experimental group, 20 to the control group. The feedback effect was analyzed using a level-2-model for discontinuous change, effect size (d), reliable change index (RCI), and odds ratio for reliable deterioration.
For patients at risk, the experimental group showed an improved outcome on the OQ-45 total scale compared to the control group (p<0.05, d=0.54). By providing feedback, the rate of reliably deteriorated patients at risk was reduced from 25.0% (control group) to 8.7% (experimental group) - odds ratio=0.29. All reliably improved patients at risk belonged to the experimental group.
Feedback improves the outcome of patients at risk undergoing psychosomatic in-patient treatment.
尽管身心医学住院治疗有效,但仍有 5-10%的患者病情恶化。为咨询师、门诊心理治疗师和物质滥用治疗师提供患者进展反馈和临床支持工具,可改善有恶化风险患者的预后。本研究调查了反馈对有身心治疗失败风险的住院患者的影响。
在入组时,两个身心医学诊所的所有患者均随机分为实验组或常规治疗对照组。两组均每周用“结果问卷”(OQ-45)评估患者进展,并采用临床支持工具“信号病例评估”(ASC)进行监测。所有实验组患者的治疗师均收到来自两种工具的反馈。“有风险的患者”定义为偏离预期恢复曲线至少一个标准差的患者。在 252 名患者中,有 43 名患者有风险:实验组 23 名,对照组 20 名。使用二级模型分析了不连续变化、效应量(d)、可靠变化指数(RCI)和可靠恶化的优势比的反馈效果。
对于有风险的患者,实验组在 OQ-45 总分上的结果优于对照组(p<0.05,d=0.54)。通过提供反馈,风险患者中可靠恶化的比例从 25.0%(对照组)降低至 8.7%(实验组)-优势比=0.29。所有可靠改善的风险患者均来自实验组。
反馈可改善身心医学住院治疗有风险患者的预后。